MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,321,523 | +142.5% | 30,338 | +101.1% | 0.00% | – |
| Q2 2023 | $544,949 | +139.6% | 15,083 | +143.3% | 0.00% | – |
| Q1 2023 | $227,441 | -15.1% | 6,199 | +4.8% | 0.00% | – |
| Q4 2022 | $267,918 | +13.5% | 5,913 | +75.2% | 0.00% | – |
| Q3 2022 | $236,000 | -9.2% | 3,375 | +90.2% | 0.00% | – |
| Q4 2021 | $260,000 | +4.0% | 1,774 | +25.7% | 0.00% | – |
| Q3 2021 | $250,000 | +23.8% | 1,411 | +13.1% | 0.00% | – |
| Q2 2021 | $202,000 | -98.1% | 1,248 | -98.0% | 0.00% | -100.0% |
| Q1 2021 | $10,584,000 | -22.8% | 61,785 | -1.0% | 0.01% | -27.3% |
| Q4 2020 | $13,706,000 | +27.4% | 62,401 | -3.7% | 0.01% | +10.0% |
| Q3 2020 | $10,756,000 | +53.4% | 64,775 | +5.5% | 0.01% | +42.9% |
| Q2 2020 | $7,012,000 | +26.0% | 61,420 | +42.2% | 0.01% | +40.0% |
| Q4 2019 | $5,566,000 | +187.9% | 43,197 | +74.1% | 0.01% | +150.0% |
| Q3 2019 | $1,933,000 | -19.7% | 24,807 | +6.1% | 0.00% | 0.0% |
| Q2 2019 | $2,407,000 | +40.0% | 23,373 | -0.3% | 0.00% | 0.0% |
| Q1 2019 | $1,719,000 | – | 23,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |